Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis
暂无分享,去创建一个
R. Kerbel | Y. Shaked | S. Man | F. S. Foster | G. Francia | Kae Hashimoto | M. Uhlik | J. Stewart | A. Dantzig | P. Xu | C. Hackl | C. Cesta | John Sun | M. Yin | Melissa Yin | Stuart Foster